Bleakley Financial Group’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,825	Closed	-$323K	–	930
2024 Q4	$323K	Buy	+5,825	New	+$323K	0.01%	770
2024 Q2	–	Sell	-6,147	Closed	-$223K	–	1056
2024 Q1	$223K	Buy	+6,147	New	+$223K	0.01%	852